The Enterprise Value as of September 2024 (TTM) for Genenta Science S.p.A. (GNTA) is 50.54M

According to Genenta Science S.p.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 50.54M. This represents a change of 36.28% compared to the average of 37.08M of the last 4 quarters.

Genenta Science S.p.A. (GNTA) Historical Enterprise Value (quarterly & annually)

How has GNTA Enterprise Value performed in the past?

The mean historical Enterprise Value of Genenta Science S.p.A. over the last ten years is 117.04M. The current 50.54M Enterprise Value has changed 4.22% with respect to the historical average. Over the past ten years (40 quarters), GNTA's Enterprise Value was at its highest in in the June 2023 quarter at 86.12M. The Enterprise Value was at its lowest in in the September 2021 quarter at -37093915.66.

Genenta Science S.p.A. (GNTA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genenta Science S.p.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genenta Science S.p.A. (GNTA) Average Enterprise Value

How has GNTA Enterprise Value performed in the past?

The current Enterprise Value of Genenta Science S.p.A. (GNTA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genenta Science S.p.A. (GNTA) Enterprise Value vs. Peers

How is GNTA’s Enterprise Value compared to its peers?

Genenta Science S.p.A.’s Enterprise Value is greater than Molecular Partners AG (-19558655.33), greater than MediciNova, Inc. (32.18M), greater than Anebulo Pharmaceuticals, Inc. (46.72M), less than Champions Oncology, Inc. (62.40M), greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than PMV Pharmaceuticals, Inc. (41.44M), less than Eliem Therapeutics, Inc. (312.10M), less than Pharvaris N.V. (643.43M), less than PepGen Inc. (255.11M), less than Mineralys Therapeutics, Inc. (513.45M), less than Janux Therapeutics, Inc. (2.53B), less than Rezolute, Inc. (266.03M), less than Opthea Limited (0), less than Pardes Biosciences, Inc. (544.82M), greater than AN2 Therapeutics, Inc. (34.92M), greater than Aerovate Therapeutics, Inc. (4.86M), greater than Adagene Inc. (24.75M), greater than null (18.97M),

Build a custom stock screener for Genenta Science S.p.A. (GNTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genenta Science S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genenta Science S.p.A. (GNTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genenta Science S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.